BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1309761)

  • 1. A vasopressin analog that binds but does not activate V1 or V2 vasopressin receptors is not internalized into cells that express V1 or V2 receptors.
    Lutz W; Londowski JM; Sanders M; Salisbury J; Kumar R
    J Biol Chem; 1992 Jan; 267(2):1109-15. PubMed ID: 1309761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Internalization of vasopressin analogs in kidney and smooth muscle cells: evidence for receptor-mediated endocytosis in cells with V2 or V1 receptors.
    Lutz W; Sanders M; Salisbury J; Kumar R
    Proc Natl Acad Sci U S A; 1990 Sep; 87(17):6507-11. PubMed ID: 2144348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The synthesis and biological activity of four novel fluorescent vasopressin analogs.
    Lutz WH; Londowski JM; Kumar R
    J Biol Chem; 1990 Mar; 265(8):4657-63. PubMed ID: 2155234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological activity of a biotinylated vasopressin analog.
    Lutz WH; Londowski JM; Kumar R
    Peptides; 1990; 11(4):687-91. PubMed ID: 2172938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and characterization of a vasopressin isoreceptor in porcine seminal vesicles.
    Maggi M; Kassis S; Malozowski S; Guardabasso V; Rodbard D
    Proc Natl Acad Sci U S A; 1986 Dec; 83(23):8824-8. PubMed ID: 2947237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terlipressin, a vasoactive prodrug recommended in hepatorenal syndrome, is an agonist of human V1, V2 and V1B receptors: Implications for its safety profile.
    Colson PH; Virsolvy A; Gaudard P; Charrabi A; Corbani M; Manière MJ; Richard S; Guillon G
    Pharmacol Res; 2016 Nov; 113(Pt A):257-264. PubMed ID: 27586252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and genetic characterization of a renal epithelial cell mutant defective in vasopressin (V2) receptor binding and function.
    Luzius H; Jans DA; Jans P; Fahrenholz F
    Exp Cell Res; 1991 Aug; 195(2):478-84. PubMed ID: 1649058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of vasopressin binding sites in rat tissues using specific V1 and V2 selective ligands.
    Phillips PA; Abrahams JM; Kelly JM; Mooser V; Trinder D; Johnston CI
    Endocrinology; 1990 Mar; 126(3):1478-84. PubMed ID: 2307115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxytocin induces a transient increase in cytosolic free [Ca2+] in renal tubular epithelial cells: evidence for oxytocin receptors on LLC-PK1 cells.
    Stassen FL; Heckman G; Schmidt D; Papadopoulos MT; Nambi P; Sarau H; Aiyar N; Gellai M; Kinter L
    Mol Pharmacol; 1988 Feb; 33(2):218-24. PubMed ID: 2828915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lateral mobility of the antagonist-occupied V2 vasopressin receptor in membranes of renal epithelial cells.
    Pavo I; Jans DA; Peters R; Penke B; Fahrenholz F
    Biochim Biophys Acta; 1994 Sep; 1223(2):240-6. PubMed ID: 8086494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxytocin receptors from LLC-PK1 cells: expression in Xenopus oocytes.
    Cantau B; Barjon JN; Chicot D; Baskevitch PP; Jard S
    Am J Physiol; 1990 Apr; 258(4 Pt 2):F963-72. PubMed ID: 2158746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The adenylate cyclase-coupled vasopressin V2-receptor is highly laterally mobile in membranes of LLC-PK1 renal epithelial cells at physiological temperature.
    Jans DA; Peters R; Zsigo J; Fahrenholz F
    EMBO J; 1989 Sep; 8(9):2481-8. PubMed ID: 2531084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasopressin receptor-mediated endocytosis: current view.
    Lutz W; Salisbury JL; Kumar R
    Am J Physiol; 1991 Jul; 261(1 Pt 2):F1-13. PubMed ID: 1650143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular cloning and functional characterization of V2 [8-lysine] vasopressin and oxytocin receptors from a pig kidney cell line.
    Gorbulev V; Büchner H; Akhundova A; Fahrenholz F
    Eur J Biochem; 1993 Jul; 215(1):1-7. PubMed ID: 8393786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular vasopressin receptors mediate inhibition of beta adrenergic receptor-induced cyclic AMP accumulation.
    Nambi P; Whitman M; Stassen FL; Crooke ST
    J Pharmacol Exp Ther; 1986 Apr; 237(1):143-6. PubMed ID: 3007735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasopressin receptor-adenylate cyclase interactions. Studies in an intact cultured renal epithelial cell line (LLC-PK1).
    Skorecki KL; Verkman AS; Ausiello DA
    Miner Electrolyte Metab; 1986; 12(1):64-70. PubMed ID: 3007962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressin V1 receptors on the principal cells of the rabbit cortical collecting tubule. Stimulation of cytosolic free calcium and inositol phosphate production via coupling to a pertussis toxin substrate.
    Burnatowska-Hledin MA; Spielman WS
    J Clin Invest; 1989 Jan; 83(1):84-9. PubMed ID: 2536047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Internalization of V2-vasopressin receptors in LLC-PK1-cells: evidence for receptor-mediated endocytosis.
    Hocher B; Merker HJ; Dürr JA; Schiller S; Gross P; Hensen J
    Biochem Biophys Res Commun; 1992 Aug; 186(3):1376-83. PubMed ID: 1387309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin II potentiates vasopressin-dependent cAMP accumulation in CHO transfected cells. Mechanisms of cross-talk between AT1A and V2 receptors.
    Klingler C; Ancellin N; Barrault MB; Morel A; Buhler JM; Elalouf JM; Clauser E; Lugnier C; Corman B
    Cell Signal; 1998 Jan; 10(1):65-74. PubMed ID: 9502119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of bacitracin on the degradation of a vasopressin receptor ligand with high affinity for the V1 and V2 vasopressin isoreceptors.
    Hocher B; Dürr JA; Hensen J
    Eur J Clin Chem Clin Biochem; 1994 Feb; 32(2):61-4. PubMed ID: 8003578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.